Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Executive or director change · Regulation FD disclosure
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 8-K Event Executive or director change
  8. 8-K Event Other events
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 8-K Event Other events
  12. 8-K Event Other events
  13. SC 13G Stake Amended Statement of Ownership
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Open-market buy Director bought 1,000 shares at an average $12.98 ($12,983)
  17. 4 Open-market buy Director bought 1,000 shares at an average $12.98 ($12,983)
  18. 4 Open-market buy Director bought 38,383 shares at an average $12.75 ($489,192)
  19. 4 Open-market buy Director bought 38,383 shares at an average $12.75 ($489,192)
  20. 4 Open-market buy Director bought 20,000 shares at an average $12.35 ($247,000)

Page 26 of 30 · 584 filings